Mechanomind
Founded Year
2015Stage
Incubator/Accelerator | AliveAbout Mechanomind
Mechanomind provides AI diagnostics for skin cancer within the healthcare technology sector. The company utilizes computer vision and deep learning to assist in the diagnosis of skin cancer, including the classification of skin tumor subtypes and offering decision support for pathologists. Mechanomind's technology is scanner and image quality agnostic, aimed at maintaining accuracy and efficiency in histopathology analysis. It was founded in 2015 and is based in New York, New York.
Loading...
Mechanomind's Product Videos
Mechanomind's Products & Differentiators
Smart Triage
Triaging pathology caseload based on diagnostic difficulty and ensuring cases are assigned to pathologists according to their specialty and optimal level of experience in order to eliminate double readings, remove bottlenecks, unburden senior pathologists from reviewing simple and standard cases, increase lab capacity through outsourcing, involving general pathologists into reviewing simple specialized cases and reducing overall cost of the diagnostic process
Loading...
Expert Collections containing Mechanomind
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Mechanomind is included in 3 Expert Collections, including Digital Health.
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Oncology Tech
571 items
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Artificial Intelligence (AI)
20,628 items
Mechanomind Frequently Asked Questions (FAQ)
When was Mechanomind founded?
Mechanomind was founded in 2015.
Where is Mechanomind's headquarters?
Mechanomind's headquarters is located at Broad Street, New York.
What is Mechanomind's latest funding round?
Mechanomind's latest funding round is Incubator/Accelerator.
Who are the investors of Mechanomind?
Investors of Mechanomind include Plug and Play.
Who are Mechanomind's competitors?
Competitors of Mechanomind include Paige and 3 more.
What products does Mechanomind offer?
Mechanomind's products include Smart Triage and 4 more.
Loading...
Compare Mechanomind to Competitors
AIRA Matrix provides Artificial Intelligence solutions for the Life Sciences sector, focusing on pathology laboratory workflows. The company offers products and services that aim to improve efficiency, diagnostic accuracy, and turnaround times in pathology, as well as provide diagnostic, prognostic, and predictive options for cancer care. AIRA Matrix serves hospitals, pharmaceutical companies, contract research organizations (CROs), and research labs globally. It was founded in 2011 and is based in Mumbai, India.
Qritive is a company that focuses on AI diagnostics in the healthcare sector, particularly in pathology. They develop AI solutions to assist pathologists in managing workflows from diagnosis to treatment. Their main offerings include a clinical-decision support system for pathologists and an image management platform called Pantheon, which are intended to support cancer diagnoses. It was founded in 2017 and is based in Singapore, Singapore.
4D Path is a company that operates within the healthcare industry. They have developed a platform that measures and quantifies cell cycle deregulations and tumor microenvironment dynamics to predict patient responses to cancer therapies. Their technology provides biomarker profiling and stratification from histopathology images. It was founded in 2016 and is based in Newton Center, Massachusetts.
Mindpeak focuses on integrating artificial intelligence in the clinical pathology sector. The company offers AI-powered diagnostic software and AI algorithms that are integrated into histology-based IVDs, including companion diagnostics, to bring precision and speed to clinical pathology. The company primarily sells to the healthcare industry, specifically pathology and university labs. It was founded in 2018 and is based in Hamburg, Germany.
Aiosyn focuses on developing precision pathology software solutions for the healthcare sector. The company offers AI-powered algorithms that enhance digital pathology workflows and support clinical diagnostics, as well as tools for the identification of pathology-based biomarkers for drug development. Aiosyn primarily serves the healthcare industry, including pathology laboratories and biopharmaceutical companies. It was founded in 2021 and is based in Nijmegen, Netherlands.
Imagene AI specializes in AI-based precision oncology within the healthcare sector, focusing on cancer research and diagnostics. The company offers a SaaS platform that integrates imaging, molecular, and clinical data to support biomarker discovery, trial design, and patient identification. Imagene AI primarily serves the healthcare and oncology research sectors with its diagnostic and treatment solutions. It was founded in 2020 and is based in Miami, Florida.
Loading...